Correlation Between Berkshire Hathaway and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Berkshire Hathaway and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Berkshire Hathaway and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Berkshire Hathaway CDR and Pfizer Inc CDR, you can compare the effects of market volatilities on Berkshire Hathaway and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Berkshire Hathaway with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Berkshire Hathaway and Pfizer.

Diversification Opportunities for Berkshire Hathaway and Pfizer

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Berkshire and Pfizer is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Berkshire Hathaway CDR and Pfizer Inc CDR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc CDR and Berkshire Hathaway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Berkshire Hathaway CDR are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc CDR has no effect on the direction of Berkshire Hathaway i.e., Berkshire Hathaway and Pfizer go up and down completely randomly.

Pair Corralation between Berkshire Hathaway and Pfizer

Assuming the 90 days trading horizon Berkshire Hathaway CDR is expected to generate 0.78 times more return on investment than Pfizer. However, Berkshire Hathaway CDR is 1.27 times less risky than Pfizer. It trades about 0.0 of its potential returns per unit of risk. Pfizer Inc CDR is currently generating about -0.08 per unit of risk. If you would invest  3,467  in Berkshire Hathaway CDR on October 26, 2024 and sell it today you would lose (4.00) from holding Berkshire Hathaway CDR or give up 0.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Berkshire Hathaway CDR  vs.  Pfizer Inc CDR

 Performance 
       Timeline  
Berkshire Hathaway CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Berkshire Hathaway CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Berkshire Hathaway is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Pfizer Inc CDR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc CDR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Berkshire Hathaway and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Berkshire Hathaway and Pfizer

The main advantage of trading using opposite Berkshire Hathaway and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Berkshire Hathaway position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
The idea behind Berkshire Hathaway CDR and Pfizer Inc CDR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing